Insider · CIK 0002091798
Tiffany Eul Davis Inglis
officer
Files at SERA (SERA PROGNOSTICS, INC.). First filing Sep 11, 2026, latest Sep 11, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $972 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SERA: SERA PROGNOSTICS, INC.
SERAOct 9, 2026 · close 2.04
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | SERA PROGNOSTICS, INC. | $972 486 shares | -1% | +29% from low-45% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | SERA SERA PROGNOSTICS, INC. | SOpen-market sale Class A Common Stock | -486 | $2.00 | $972 | 91,589 | 32 d ago |
| Mar 12, 2026 | SERA SERA PROGNOSTICS, INC. | AGrant or award Class A Common Stock | +17,437 | $0.00 | $0 | 92,437 | Mar 13, 2026 |
| Mar 12, 2026 | SERA SERA PROGNOSTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +27,034 | $0.00 | $0 | 27,034 | Mar 13, 2026 |
| Oct 15, 2025 | SERA SERA PROGNOSTICS, INC. | AGrant or award Class A Common Stock | +75,000 | $0.00 | $0 | 75,000 | Oct 15, 2025 |
| Oct 15, 2025 | SERA SERA PROGNOSTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +107,000 | $0.00 | $0 | 107,000 | Oct 15, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.